Catherine Coste
Directeur/Membre du Conseil chez BIOMERICA, INC.
Fortune : 29 564 $ au 30/04/2024
Postes actifs de Catherine Coste
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOMERICA, INC. | Directeur/Membre du Conseil | 03/09/2020 | - |
| Independent Dir/Board Member | 03/09/2020 | - | |
| MINERVA SURGICAL, INC. | Directeur/Membre du Conseil | 01/02/2021 | - |
| Independent Dir/Board Member | 01/02/2021 | - | |
| RENALYTIX PLC | Directeur/Membre du Conseil | 30/06/2023 | - |
| Independent Dir/Board Member | 30/06/2023 | - |
Historique de carrière de Catherine Coste
Anciens postes connus de Catherine Coste
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/08/1988 | 01/09/2020 |
Formation de Catherine Coste
| The California State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMERICA, INC. | Health Technology |
| MINERVA SURGICAL, INC. | Health Technology |
| RENALYTIX PLC | Technology Services |
| Entreprise privées | 1 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Catherine Coste
- Expérience
